![Jim McKinnis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jim McKinnis
Corporate Officer/Principal chez The Integer Group LLC
Postes actifs de Jim McKinnis
Sociétés | Poste | Début | Fin |
---|---|---|---|
The Integer Group LLC
![]() The Integer Group LLC Miscellaneous Commercial ServicesCommercial Services The Integer Group LLC operates as commerce agencies. The company was founded in 1993 and is headquartered in Denver, CO. | Corporate Officer/Principal | - | - |
The Leukemia & Lymphoma Society, Inc.
![]() The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Corporate Officer/Principal | - | - |
Historique de carrière de Jim McKinnis
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Corporate Officer/Principal | 2 |
Sectorielle
Commercial Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
The Integer Group LLC
![]() The Integer Group LLC Miscellaneous Commercial ServicesCommercial Services The Integer Group LLC operates as commerce agencies. The company was founded in 1993 and is headquartered in Denver, CO. | Commercial Services |
The Leukemia & Lymphoma Society, Inc.
![]() The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Commercial Services |
- Bourse
- Insiders
- Jim McKinnis
- Expérience